Metraipolis › archive › dc_e37047ac2d50

Impact of new regimens and drugs on rifampin-resistant tuberculosis management in Mexico — Europe PMC PMID:41417304

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41417304
DOI
10.36416/1806-3756/e20250131
License (as archived)
solo-consultazione
Archived
2026-11-07T16:53:40.265Z
SHA-256 of the archived text
cd86686da514329abbc7f886efb8bb7df2bbf8a00d950d1ec814783659da0c44
Stable URL of this page
https://metraipolis.com/documento/dc_e37047ac2d50

How to cite

Impact of new regimens and drugs on rifampin-resistant tuberculosis management in Mexico — Europe PMC PMID:41417304 — Europe PMC (en), https://europepmc.org/article/MED/41417304 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e37047ac2d50 (Metraipolis archive dc_e37047ac2d50, sha256 cd86686da514329abbc7f886efb8bb7df2bbf8a00d950d1ec814783659da0c44)
BibTeX
@misc{dce37047ac2d50,
  title = {Impact of new regimens and drugs on rifampin-resistant tuberculosis management in Mexico — Europe PMC PMID:41417304},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41417304},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e37047ac2d50; sha256 cd86686da514329abbc7f886efb8bb7df2bbf8a00d950d1ec814783659da0c44},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41417304. Agents can read the archived copy with the MCP tool read_document.